HIV/AIDS

October 16, 2014

BHT grant to help Comprehensive Care Clinic’s medication program

The Vanderbilt Comprehensive Care Clinic has received a nearly $54,000 grant for 2014-2015 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS.

By Bill Snyder
HIV cell
October 2, 2014

Traditional healers contribute to HIV care delays: study

If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer.

By Paul Govern
A smiling woman in her 50s in front of a rock wall.
September 11, 2014

Study tracks new way to fight HIV infection in women

Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection.

By Bill Snyder
January 30, 2014

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

By Bill Snyder
HIV cell
January 15, 2014

HIV’s impact on B cells

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.

By Leigh MacMillan
Pills
November 7, 2013

Grant bolsters HIV pharmacy support program

The Vanderbilt Comprehensive Care Clinic has received a nearly $40,000 grant for 2013-2014 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS.

By Bill Snyder
July 15, 2013

Defining patient retention

Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations.
By Leigh MacMillan
January 24, 2013

Genetic testing just one weapon in HIV/AIDS fight

Genetic testing has revolutionized the treatment of patients with HIV/AIDS. But it is not a panacea.
By Bill Snyder
November 8, 2012

Study seeks to ease HIV transmission rates in Nigeria

Researchers at the Vanderbilt Institute for Global Health (VIGH) have received a major federal grant to study whether an integrated, family-focused approach can prevent mother-to-child transmission of HIV — the AIDS virus — in Nigeria.
By Bill Snyder
October 25, 2012

HIV/AIDS-related efforts in Africa get $7 million boost

Vanderbilt University has received a major federal grant — just more than $7 million in the first year — to extend HIV/AIDS-related technical assistance and training in the rural province of Zambézia, Mozambique.
By Bill Snyder
October 5, 2012

Host proteins can control HIV infection

The protein APOBEC3G contributes to spontaneous control of HIV-1 in vivo and may provide therapeutic benefits.
By Leigh MacMillan
August 2, 2012

VU research shines at international AIDS meet

Vanderbilt University’s Vikrant Sahasrabuddhe, M.D., MPH, DrPH, received the IAS/ANRS Young Investigator Award at the International AIDS Conference last week in Washington, D.C.
By Bill Snyder
August 2, 2012

Early HIV treatment also can prevent TB: study

Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.
By Bill Snyder
1 … 4 5 6 7